A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine
- 12 November 2004
- journal article
- research article
- Published by Elsevier BV in Brain Research
- Vol. 1026 (2), 244-253
- https://doi.org/10.1016/j.brainres.2004.08.027
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinenceNeuropharmacology, 2002
- Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid systemNeuroscience, 2001
- Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuseBehavioural Brain Research, 2001
- Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained respondingPharmacology Biochemistry and Behavior, 2000
- Cannabinoid receptors and reward in the rat: a conditioned place preference study.Psychopharmacology, 2000
- The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716.Psychopharmacology, 1999
- Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaineEuropean Journal of Pharmacology, 1998
- Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.Psychopharmacology, 1998
- New dawn of cannabinoid pharmacologyTrends in Pharmacological Sciences, 1994
- Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysisPsychopharmacology, 1990